347 related articles for article (PubMed ID: 17107535)
1. Sarcomatoid renal cell carcinoma: rapid dissemination detected on FDG PET-CT.
Thambugala GM; Mohamed A; O' Neill GF; Fulham MJ
Australas Radiol; 2006 Dec; 50(6):604-6. PubMed ID: 17107535
[TBL] [Abstract][Full Text] [Related]
2. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
Ramdave S; Thomas GW; Berlangieri SU; Bolton DM; Davis I; Danguy HT; Macgregor D; Scott AM
J Urol; 2001 Sep; 166(3):825-30. PubMed ID: 11490227
[TBL] [Abstract][Full Text] [Related]
3. FDG PET/CT and CT Findings of Renal Cell Carcinoma With Sarcomatoid Differentiation.
Zhu H; Zhao S; Zuo C; Ren F
AJR Am J Roentgenol; 2020 Sep; 215(3):645-651. PubMed ID: 32755159
[No Abstract] [Full Text] [Related]
4. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma.
Majhail NS; Urbain JL; Albani JM; Kanvinde MH; Rice TW; Novick AC; Mekhail TM; Olencki TE; Elson P; Bukowski RM
J Clin Oncol; 2003 Nov; 21(21):3995-4000. PubMed ID: 14581422
[TBL] [Abstract][Full Text] [Related]
5. Sarcomatoid renal cell carcinoma: a case report and literature review.
Liang X; Liu Y; Ran P; Tang M; Xu C; Zhu Y
BMC Nephrol; 2018 Apr; 19(1):84. PubMed ID: 29636020
[TBL] [Abstract][Full Text] [Related]
6. F-18 FDG PET findings in a port site recurrence after laparoscopic radical nephrectomy in a patient with renal cell carcinoma.
Malhotra G; Nair N; Abhyankar A; Awasare S; Moghe SH
Clin Nucl Med; 2008 Feb; 33(2):146-7. PubMed ID: 18209545
[No Abstract] [Full Text] [Related]
7. FDG PET/CT of Chromophobe Renal Cell Carcinoma With Sarcomatoid Differentiation.
Lee CH; Kesari V; Legesse T; Chen W
Clin Nucl Med; 2018 May; 43(5):367-369. PubMed ID: 29485439
[TBL] [Abstract][Full Text] [Related]
8. Unusual metastatic sites from renal cell carcinoma detected by 18F-FDG PET/CT scan.
Aurangabadkar H; Ali Z
Clin Nucl Med; 2013 Dec; 38(12):e471-3. PubMed ID: 23603603
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of F-18 FDG PET/CT for local and distant disease relapse surveillance in surgically treated RCC patients: Can it aid in establishing consensus follow up strategy?
Elahmadawy MA; Elazab MSS; Ahmed S; Salama M
Nucl Med Rev Cent East Eur; 2018; 21(2):85-91. PubMed ID: 30070347
[TBL] [Abstract][Full Text] [Related]
10. Primary synovial sarcoma of the kidney: use of PET/CT in diagnosis and follow-up.
Erturhan S; Seçkiner I; Zincirkeser S; Erbagci A; Celik M; Yagci F; Karakok M
Ann Nucl Med; 2008 Apr; 22(3):225-9. PubMed ID: 18498039
[TBL] [Abstract][Full Text] [Related]
11. Better late than early: FDG-PET imaging in metastatic renal cell carcinoma.
Harrison MR; George DJ
Clin Cancer Res; 2011 Sep; 17(18):5841-3. PubMed ID: 21926167
[TBL] [Abstract][Full Text] [Related]
12. Role of FDG PET-CT in recurrent renal cell carcinoma.
Kumar R; Shandal V; Shamim SA; Jeph S; Singh H; Malhotra A
Nucl Med Commun; 2010 Oct; 31(10):844-50. PubMed ID: 20661166
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT in a patient affected by renal collecting duct (Bellini) carcinoma.
Bertagna F; Fisogni S; Tardanico R; Simeone C; Cunico SC; Giubbini R
Clin Nucl Med; 2012 Oct; 37(10):986-8. PubMed ID: 22955073
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma presenting as isolated deltoid muscle metastasis 12 years after radical nephrectomy detected on 18F-FDG PET/CT.
Bhoil A; Mittal BR; Bhattacharya A; Rane S; Nijhawan R; Gupta V
Clin Nucl Med; 2013 Dec; 38(12):e474-6. PubMed ID: 23579976
[TBL] [Abstract][Full Text] [Related]
15. Widespread metastases from sarcomatoid renal cell carcinoma detected by (18)F-FDG positron emission tomography/computed tomography.
Hyodo T; Sugawara Y; Tsuda T; Yanagihara Y; Aoki K; Tanji N; Hirata M; Murakami M; Miyagawa M; Yokoyama M; Mochizuki T
Jpn J Radiol; 2009 Feb; 27(2):111-4. PubMed ID: 19373542
[TBL] [Abstract][Full Text] [Related]
16. A rare presentation of metastatic renal clear cell carcinoma to the tongue seen on FDG PET.
Basely M; Bonnel S; Maszelin P; Verdalle P; Bussy E; de Jaureguiberry JP
Clin Nucl Med; 2009 Sep; 34(9):566-9. PubMed ID: 19692815
[TBL] [Abstract][Full Text] [Related]
17. Does F-18 FDG-PET still play a role in metastatic renal cell carcinoma?
Mennitto A; Grassi P; Verzoni E; Ratta R; Procopio G
J Med Imaging Radiat Oncol; 2017 Apr; 61(2):250-251. PubMed ID: 28070961
[No Abstract] [Full Text] [Related]
18. Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma.
Karivedu V; Jain AL; Eluvathingal TJ; Sidana A
Curr Urol Rep; 2019 Aug; 20(10):56. PubMed ID: 31468240
[TBL] [Abstract][Full Text] [Related]
19. [PET/CT with (18F)FDG in the initial staging of a pelvic kidney neoplasm. A case report].
Pifarré Montaner P; Simó Perdigó M; Plaza López P; Marco V; Alvarez Castells A; Martínez-Miralles E
Rev Esp Med Nucl; 2009; 28(4):200-3. PubMed ID: 19922833
[TBL] [Abstract][Full Text] [Related]
20. PET scans for decision-making in metastatic renal cell carcinoma: a single-institution evaluation.
Dilhuydy MS; Durieux A; Pariente A; de Clermont H; Pasticier G; Monteil J; Ravaud A
Oncology; 2006; 70(5):339-44. PubMed ID: 17164590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
